Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-10-11

Clinical Trial Update: Vaccine Treatment of Kidney Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of a kidney cancer vaccine sponsored by the National Cancer Institute was terminated, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Kidney Cancer | Phase 2 | Status: TERMINATED | Results posted: 2012-10-11